Overexpression of cyclooxygenase-2 in NCI-H292 human alveolar epithelial carcinoma cells: Roles of p38 MAPK, ERK-1/2, and PI3K/PKB signaling proteins

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 3015-3024

  Sung, Suhaeng ^a,c   Park, Yukyoung ^a   Jo, Jeong Rang ^a   Jung, Nak Kyun ^a   Song, Dae Kyu ^a   Bae, Jaehoon ^a   Keum, Dong Yun ^a   Kim, Jae Bum ^a   Park, Gy Young ^b   Jang, Byeong Churl ^a   Park, Jong Wook ^a  

^a Keimyung University School of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

COX 2; ERK 1 2; NCI H292 cells; p38 MAPK; PKB

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ALVEOLAR EPITHELIAL CARCINOMA; ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; HUMANS; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; PROTEIN STABILITY; RNA STABILITY; SIGNAL TRANSDUCTION;

EID: 80053209811     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23226     Document Type: Article

References (47)

1. Balmanno K, Cook SJ,. 2009. Tumour cell survival signaling by the ERK1/2 pathway. Cell Death and Differentiation 16: 368-377.
2. Cao Z, Liu LZ, Dixon DA, Zheng JZ, Chandran B, Jiang BH,. 2007. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells. Cell Sign 19: 1542-1553. (Pubitemid 46824175)
3. Chen W, Tang Q, Gonzales MS, Bowden GT,. 2001. Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 20: 3921-3926. (Pubitemid 32646203)
4. Cho JW, Park K, Kweon GR, Jang BC, Beak WK, Suh MH, Kim CW, Lee KS, Suh SI,. 2005. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 37: 186-192. (Pubitemid 40992733)
5. Cohen P,. 1997. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7: 353-361. (Pubitemid 27384781)
6. Cok SJ, Morrison AR,. 2001. The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 276: 23179-23185.
7. Czembirek C, Eder-Czembirek C, Erovic BM, Turhani D, Spittler A, Selzer E, Pötter R, Thurnher D,. 2009. The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells. Strahlenther Onkol 185: 310-317.
8. Dean JL, Brook M, Clark AR, Saklatvala J,. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 274: 264-269. (Pubitemid 29035058)
9. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky P,. 1998. Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073. (Pubitemid 28418937)
10. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN,. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188. (Pubitemid 24294584)
11. Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR,. 1998. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 273: 28670-28676. (Pubitemid 28507552)
12. Hawk ET, Viner JL, Dannenberg A, DuBois RN,. 2002. COX-2 in cancer-A player that's defining the rules. J Natl Cancer Inst 94: 545-546. (Pubitemid 34498637)
13. Herschman HR, Reddy ST, Xie W,. 1997. Function and regulation of prostaglandin synthase-2. Adv Exp Med Biol 407: 61-66. (Pubitemid 27440707)
14. Hla T, Ristimaki A, Appleby SB, Barriocanal JG,. 1993. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann NY Acad Sci 696: 197-204. (Pubitemid 24062788)
15. Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA,. 2004. JNK-mediated induction of cyclooxygenase is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 101: 665-670. (Pubitemid 38084694)
16. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T,. 1995. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 270: 24965-24971.
17. Jang BC, Sanchez T, Schaefers HJ, Trifan OC, Liu CH, Creminon C, Huang CK, Hla T,. 2000. Serum withdrawal-induced posttranscriptional stabilization of cyclooxygenase-2 mRNA in MDAMB- 231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. J Biol Chem 275: 39507-39515. (Pubitemid 32058977)
18. Jang BC, Muñoz-Najar U, Paik JH, Claffey K, Yoshida M, Hla T,. 2003. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem 278: 2773-2776. (Pubitemid 36801177)
19. Jang BC, Kim DH, Park JW, Kwon TK, Kim SP, Song DK, Park JG, Bae JH, Mun KC, Baek WK, Suh MH, Hla T, Suh SI,. 2004. Induction of cyclooxygenase-2 in macrophages by catalase: Role of NF-kappaB and PI3K signaling pathways. Biochem Biophys Res Commun 316: 398-406. (Pubitemid 38338606)
20. Jang BC, Paik JH, Kim SP, Shin DH, Song DK, Park JG, Suh MH, Park JW, Suh SI,. 2005. Catalase induced expression of inflammatory mediators via activation of NF-B, PI3K/AKT, p70S6K, and JNKs in BV2 microglia. Cell Sign 17: 625-633.
21. Jang BC, Sung SH, Park JG, Park JW, Bae JH, Shin DH,. 2007. Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner. J Biol Chem 282: 27622-27632.
22. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL,. 2007. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 46: 108-125. (Pubitemid 46661865)
23. Kurihara Y, Hatori M, Ando Y, Ito D, Toyoshima T, Tanaka M, Shintani S,. 2009. Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation. Clin Exp Metastasis 26: 425-432.
24. Liu JF, Jamieson G, Wu TC, Zhang SW, Wang QZ, Drew P,. 2006. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Dis Esophagus 19: 350-354. (Pubitemid 44390440)
25. Mbonye UR, Wada M, Rieke CJ, Tang HY, Dewitt DL, Smith WL,. 2006. The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J Biol Chem 281: 35770-35778. (Pubitemid 46041308)
26. Mbonye UR, Yuan C, Harris CE, Sidhu RS, Song I, Arakawa T,. 2008. Two distinct pathways for cyclooxygenase-2 protein degradation. J Biol Chem 283: 8611-8623.
27. Mutter R, Lu B, Carbone DP, Csiki I, Moretti L, Johnson DH, Morrow JD, Sandler AB, Shyr Y, Ye F, Choy H,. 2009. A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer. Clin Cancer Res 15: 2158-2165.
28. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ,. 1997. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 237: 28-32. (Pubitemid 27390317)
29. Otto JC, DeWitt DL, Smith WL,. 1993. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J Biol Chem 268: 18234-18242. (Pubitemid 23260348)
30. Park SW, Kim HS, Hah JW, Jeong WJ, Kim KH, Sung MW,. 2010. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines. Anticancer Drugs Aug 16.
31. Petkova DK, Clelland C, Ronan J, Pang L, Coulson JM, Lewis S, Knox AJ,. 2004. Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respir Med 98: 164-172. (Pubitemid 38181136)
32. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR, Saklatvala J,. 1998. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclo- oxygenase-2 mRNA. FEBS Lett 439: 75-80. (Pubitemid 28537867)
33. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T,. 1994. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 269: 11769-11775.
34. Sengupta S, Jang BC, Wu MT, Paik JH, Furneaux H, Hla T,. 2003. The RNA binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem 278: 25227-25233. (Pubitemid 37548687)
35. Sheng H, Shao J, Dixon DA, Williams CS, Prescott SM, DuBois RN, Beauchamp RD,. 2000. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem 275: 33951-33956.
36. Smith WL, DeWitt DL,. 1996. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62: 167-215. (Pubitemid 26250630)
37. Smith WL, DeWitt DL, Garavito RM,. 2000. Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182.
38. Srivastava SK, Tetsuka T, Daphna-Iken D, Morrison AR,. 1994. IL-1 beta stabilizes COX II mRNA in renal mesangial cells: Role of 3'-untranslated region. Am J Physiol 267: 504-508.
39. Stauffer F, Holzer P, García-Echeverría C,. 2005. Blocking the PI3K/PKB pathway in tumor cells. Curr Med Chem Anticancer Agents 5: 449-462. (Pubitemid 41166514)
40. Talmadge JE, Hood KC, Zobel LC, Shafer LR, Coles M, Toth B,. 2007. Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion. Int Immunopharmacol 7: 140-151. (Pubitemid 46043318)
41. Tong M, Ding Y, Tai HH,. 2006. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Carcinogenesis 27: 2170-2179. (Pubitemid 44644805)
42. Vane JR, Bakhle YS, Botting RM,. 1998. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120. (Pubitemid 28231490)
43. Xu L, Pathak PS, Fukumura D,. 2004. Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3'-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells. Clin Cancer Res 10: 701-707. (Pubitemid 38174009)
44. Yang X, Liu S, Liu Y, Liu J, Liu T, Wang X, Yan Q,. 2010. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways. J Cell Physiol 225: 612-619.
45. Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA,. 2009. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136: 1669-1679.
46. Zhang Z, Sheng H, Shao J, Beauchamp RD, DuBois RN,. 2000. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia 2: 523-530. (Pubitemid 32098687)
47. Zhang MZ, Xu J, Yao B, Yin H, Cai Q, Shrubsole MJ, Chen X, Kon V, Zheng W, Pozzi A, Harris RC,. 2009. Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J Clin Invest 119: 876-885.